A Collaborative Approach for Service- and Solution-Providers Working in the Life Sciences — A Conversation with Yash Sabharwal of QbDVision

The bluEPrint by Executive Platforms

At the 2023 edition of the Biomanufacturing World Summit series we sat down with Yash Sabharwal, the CEO and Co-Founder of QbDVision, to talk about a real opportunity available to companies working in the Life Sciences right now. So many new and exciting things are happening right now as the biopharmaceutical industry prepares to create the next generation of ATMPs like Cell and Gene Therapies —and at the same time most companies are behind the curve on adopting many digital solutions— what if everyone working in this space collaborated together to forge interconnected, interoperable, self-reinforcing systems? In a ‘growing the pie gets everyone a bigger slice’ mindset, service- and solution-providers contributing to a shared infrastructure that speaks the same language, moves data where needed seamlessly, documents and demonstrates compliance, and offers users a shared training base is going to produce a better outcome for everyone without the wasted effort of competition. What would that look like in real terms? Yash and other industry leaders like him are actively building a community approach to how their tools work together to help everyone. Give this episode a listen to learn more!

--

Yash Sabharwal

Director, CEO, Co-Founder

Yash Sabharwal is an accomplished inventor, entrepreneur, and executive specializing in the funding and growth of early-stage technology companies focused on life science applications. He has started 3 companies and successfully exited his last two, bringing a wealth of strategic and tactical experience to the team.

--

QbDVision, Inc.

QbDVision is an innovative software company pioneering the development of modern digital solutions for the pharma/biotech industry to accelerate the manufacturing development cycle, increase the probability of technical success, and help get therapeutic breakthroughs to patients that much faster.

For many of the newest therapies being developed, the associated manufacturing processes are complex and the next generation of software solutions need to move the industry away from document-centric and spreadsheet-centric information management. QbDVision has assembled a group of industry veterans with 100+ years of collective experience in process development, tech transfer, pharmaceutical quality, and regulatory compliance to develop the next generation of structured data solutions that will dramatically increase R&D efficiency.

www.qbdvision.com